Toshiaki Takeichi
About
In The Last Decade
Toshiaki Takeichi
22 papers receiving 350 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 112
- Cellular and Molecular Neuroscience 76
- Neurology 62
- Epidemiology 38
- Infectious Diseases 33
Countries citing papers authored by Toshiaki Takeichi
This map shows the geographic impact of Toshiaki Takeichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Takeichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Takeichi more than expected).
Fields of papers citing papers by Toshiaki Takeichi
This network shows the impact of papers produced by Toshiaki Takeichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Takeichi. The network helps show where Toshiaki Takeichi may publish in the future.
Co-authorship network of co-authors of Toshiaki Takeichi
This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Takeichi. A scholar is included among the top collaborators of Toshiaki Takeichi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Takeichi. Toshiaki Takeichi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 0 | |
| 6 | 30 | |
| 7 | 38 | |
| 8 | 14 | |
| 9 | 22 | |
| 10 | 52 | |
| 11 | 40 | |
| 12 | 63 | |
| 13 | 2 | |
| 14 | 27 | |
| 15 | Multiple hepatocellular carcinomas developed 15 months after commencement of chemotherapy for elderly acute myelogenous leukemia. | 1 |
| 16 | [A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy]. | 3 |
| 17 | 9 | |
| 18 | 16 | |
| 19 | 9 | |
| 20 | Antigenic variant (WFT-2N) of a transplantable rat tumor induced by Friend virus. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.